The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl 3-benzyl-1-methyl-4-oxo-9-phenyl-3,4-dihydropyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-6-yl-propanoate ID: ALA215699
PubChem CID: 11850082
Max Phase: Preclinical
Molecular Formula: C26H23N5O3
Molecular Weight: 453.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)CCc1nc2c(=O)n(Cc3ccccc3)nc(C)c2c2cc(-c3ccccc3)nn12
Standard InChI: InChI=1S/C26H23N5O3/c1-17-24-21-15-20(19-11-7-4-8-12-19)29-31(21)22(13-14-23(32)34-2)27-25(24)26(33)30(28-17)16-18-9-5-3-6-10-18/h3-12,15H,13-14,16H2,1-2H3
Standard InChI Key: MUWBQLYNPGYQGE-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
12.2645 -9.1265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0928 -9.1264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5088 -8.4130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1004 -7.7070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2683 -7.7031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8523 -8.4132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2607 -10.5538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8485 -9.8404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5050 -9.8403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0906 -10.5526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6414 -11.1660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3939 -10.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3096 -10.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8614 -6.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2762 -6.2723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1007 -6.2823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5192 -5.5700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1084 -4.8514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2787 -4.8494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8677 -5.5624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3343 -8.4154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1087 -11.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1025 -12.0691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8126 -12.4810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5296 -12.0712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5282 -11.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8137 -10.8295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8514 -11.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0259 -11.2717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6127 -11.9880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7873 -11.9897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0289 -12.7025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3749 -11.2752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0307 -8.4107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15 16 2 0
7 8 2 0
16 17 1 0
9 2 1 0
17 18 2 0
1 8 1 0
18 19 1 0
9 10 1 0
19 20 2 0
20 15 1 0
1 6 1 0
3 21 1 0
2 3 1 0
12 22 1 0
3 4 2 0
22 23 2 0
4 5 1 0
23 24 1 0
5 6 1 0
24 25 2 0
10 11 1 0
25 26 1 0
11 12 2 0
26 27 2 0
27 22 1 0
12 13 1 0
7 28 1 0
13 9 2 0
28 29 1 0
7 10 1 0
29 30 1 0
5 14 1 0
30 31 1 0
30 32 2 0
14 15 1 0
31 33 1 0
1 2 2 0
6 34 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 453.50Molecular Weight (Monoisotopic): 453.1801AlogP: 3.57#Rotatable Bonds: 6Polar Surface Area: 91.38Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.63CX LogD: 3.63Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.37Np Likeness Score: -1.33
References 1. Giovannoni MP, Vergelli C, Biancalani C, Cesari N, Graziano A, Biagini P, Gracia J, Gavaldà A, Dal Piaz V.. (2006) Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction., 49 (17): [PMID:16913726 ] [10.1021/jm060265+ ]